PESARINI, Gabriele
 Distribuzione geografica
Continente #
EU - Europa 5.130
NA - Nord America 4.711
AS - Asia 3.721
SA - Sud America 457
AF - Africa 148
Continente sconosciuto - Info sul continente non disponibili 117
OC - Oceania 13
Totale 14.297
Nazione #
US - Stati Uniti d'America 4.589
RU - Federazione Russa 2.325
SG - Singapore 1.527
CN - Cina 1.023
GB - Regno Unito 884
IT - Italia 544
BR - Brasile 360
HK - Hong Kong 337
VN - Vietnam 319
FR - Francia 258
DE - Germania 251
SE - Svezia 229
IE - Irlanda 192
FI - Finlandia 187
KR - Corea 132
CA - Canada 66
IN - India 65
BD - Bangladesh 51
NL - Olanda 45
UA - Ucraina 42
ID - Indonesia 39
AR - Argentina 35
MX - Messico 35
ZA - Sudafrica 34
TR - Turchia 33
JP - Giappone 31
PL - Polonia 30
TG - Togo 30
NG - Nigeria 29
ES - Italia 28
IQ - Iraq 28
BE - Belgio 21
BJ - Benin 21
UZ - Uzbekistan 18
CO - Colombia 16
PK - Pakistan 16
EC - Ecuador 15
MA - Marocco 14
LT - Lituania 13
VE - Venezuela 13
AT - Austria 11
CZ - Repubblica Ceca 11
IR - Iran 11
AZ - Azerbaigian 10
IL - Israele 9
KG - Kirghizistan 9
AU - Australia 8
CH - Svizzera 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
AL - Albania 6
CL - Cile 6
OM - Oman 6
RO - Romania 6
TN - Tunisia 6
HU - Ungheria 5
JM - Giamaica 5
NP - Nepal 5
BG - Bulgaria 4
DK - Danimarca 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
TH - Thailandia 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
HR - Croazia 3
LV - Lettonia 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PY - Paraguay 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BZ - Belize 2
EE - Estonia 2
EG - Egitto 2
GT - Guatemala 2
KH - Cambogia 2
LB - Libano 2
MT - Malta 2
PA - Panama 2
TJ - Tagikistan 2
AO - Angola 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
IS - Islanda 1
KI - Kiribati 1
Totale 14.167
Città #
Moscow 824
Singapore 802
Southend 742
Ashburn 699
San Jose 555
Dallas 396
Chandler 368
Hong Kong 334
Jacksonville 225
Beijing 210
Verona 199
Dublin 190
New York 182
The Dalles 157
Los Angeles 124
Council Bluffs 106
Ho Chi Minh City 103
Helsinki 97
Munich 97
Woodbridge 96
Hanoi 85
Ann Arbor 82
Houston 74
Jinan 66
Lawrence 58
Princeton 58
Wilmington 52
Santa Clara 50
Shenyang 49
São Paulo 49
Buffalo 41
Milan 40
London 39
Tianjin 39
Nanjing 37
Redondo Beach 37
Orem 35
Hebei 34
Turku 32
Seattle 31
Lomé 30
Montreal 30
Seoul 29
Columbus 27
Frankfurt am Main 27
Tokyo 27
Rome 26
Sindelfingen 26
Warsaw 25
Abuja 24
Chennai 24
Denver 24
Johannesburg 24
Amsterdam 23
Nanchang 23
Taizhou 23
Zhengzhou 23
Changsha 22
Atlanta 21
Brooklyn 21
Cedar Knolls 21
Cotonou 21
Guangzhou 21
Brussels 20
Haikou 20
Stockholm 20
Toronto 20
Washington 20
Phoenix 18
Taiyuan 18
Da Nang 17
Ningbo 17
Falkenstein 16
Kent 16
Poplar 16
Haiphong 15
Hangzhou 15
Jakarta 15
San Francisco 15
Tashkent 15
Baghdad 14
Boston 14
Nuremberg 14
Paris 14
Lappeenranta 13
Redwood City 13
Chicago 12
Jiaxing 12
Rio de Janeiro 12
Belo Horizonte 11
Fairfield 11
Mexico City 11
Norwalk 11
Shanghai 11
Biên Hòa 10
Brasília 10
Fuzhou 10
Lanzhou 10
Madrid 10
Baku 9
Totale 8.581
Nome #
Clinical outcomes of transcatheter aortic valve implantation: from learning curve to proficiency 590
MODULAZIONE DELLA RISPOSTA INFIAMMATORIA NELLA PREVENZIONE DELLA RESTENOSI POST STENT CORONARICO: IL TRIAL CLINICO MULTICENTRICO RANDOMIZZATO “CEREA-DES” 217
Coronary Catheterization and Percutaneous Interventions After Transcatheter Aortic Valve Implantation 215
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 206
Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions 204
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 197
"Valve in valve" implantation of two self-expandable transcatheter aortic valves in a patient with aortic root aneurysm and massive aortic regurgitation: "a new TAVI option" 194
"Cardiac allograft vasculopathy: Pathogenesis, diagnosis and therapy" 190
Angiography-Derived Index of Microcirculatory Resistance to Define the Risk of Early Discharge in STEMI 188
Hemodynamic predictors of long term survival in end stage cystic fibrosis 187
Correlation between intracoronary physiology and myocardial perfusion imaging in patients with severe aortic stenosis 186
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 184
Immediate and long-term clinical performance of bioresorbable vascular scaffolds in a real world population 183
A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. 179
Comparative Prognostic Value of Parameters of Pulsatile Right Ventricular Afterload in Patients With Advanced Heart Failure Awaiting Heart Transplantation 177
Coronary physiology in patients with severe aortic stenosis: Comparison between fractional flow reserve and instantaneous wave-free ratio 176
Functional Assessment of Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation Influence of Pressure Overload on the Evaluation of Lesions Severity 176
Physiologic Evaluation of Coronary Lesions Using Instantaneous Wave-free Ratio (iFR) in Patients with Severe Aortic Stenosis Undergoing Trans-catheter Aortic Valve Implantation 176
Effectiveness and Safety of Transcatheter Aortic Valve Implantation in Patients With Pure Aortic Regurgitation and Advanced Heart Failure 171
Physiological Versus Angiographic Guidance for Myocardial Revascularization in Patients Undergoing Transcatheter Aortic Valve Implantation 169
Transcatheter valve-in-mitral homograft in tricuspid position: first-in-man report 167
Impella-protected PCI: the clinical results achieved so far 166
Coronary artery disease in patients undergoing transcatheter aortic valve implantation. A single centre registry on prevalence, management and immediate clinical impact 163
Observations from a real-time, iFR-FFR "hybrid approach" in patients with severe aortic stenosis and coronary artery disease undergoing TAVI 161
The Activated Clotting Time Paradox: Relationship Between Activated Clotting Time and Occlusion of the Radial Artery When Used as Vascular Access for Percutaneous Coronary Procedures 161
iFR-FFR comparison in daily practice: a single-center, prospective, online assessment 161
Devices for mechanical circulatory support and strategies for their management in cardiogenic shock 160
Intravascular ultrasound assessment of coronary ostia following valve in valve transcatheter aortic valve implantation 160
Contrast-Induced Nephropathy in Patients Undergoing Staged Versus Concomitant Transcatheter Aortic Valve Implantation and Coronary Procedures 158
Acute electrocardiographic differences between Takotsubo cardiomyopathy and anterior ST elevation myocardial infarction 158
Volume of contrast to creatinine clearance ratio predicts early mortality and AKI after TAVI 157
Proof of concept study on coronary microvascular function in low flow low gradient aortic stenosis 153
Clinical outcome after endovascular, surgical or hybrid revascularisation in patients with combined carotid and coronary artery disease: the Finalised Research In ENDovascular Strategies Study Group (FRIENDS). 153
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 152
Coronary microvascular dysfunction in patients undergoing transcatheter aortic valve implantation 151
Angiography-derived index of microvascular resistance in takotsubo syndrome 151
Late and very late coronary stent thrombosis: Intravascular ultrasound findings and associations with antiplatelet therapy 148
Characterisation of coronary microvascular dysfunction in patients with severe aortic stenosis undergoing TAVI 146
Impact of physiologically diffuse versus focal pattern of coronary disease on quantitative flow reserve diagnostic accuracy 146
Long-term variations of FFR and iFR after transcatheter aortic valve implantation 146
Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. 145
Cytokines release inhibition from activated monocytes, and reduction of in-stent neointimal growth in humans. 144
New-onset extreme right axis deviation in acute myocardial infarction: clinical characteristics and outcomes 144
Long-term follow-up after trans-catheter tricuspid valve-in-valve replacement with balloon-expandable aortic valves 143
Optimal timing for percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation 142
Comparison of the long-term survival benefits associated with revascularization or medical therapy in patients with known coronary artery disease undergoing transesophageal atrial pacing stress echocardiography 140
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes 139
Risk stratification in acute coronary syndromes. 137
Transapical mitral valve-in-valve procedure with elective venoarterial ECMO in a patient with severe kyphoscoliosis 133
Extravalvular Cardiac Damage and Renal Function Following Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis 133
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 133
Bail-out transcatheter aortic valve implantation to reduce severe acute aortic regurgitation in a failing homograft secondary to HeartMate II ventricular assistance device 132
First Observation of a "Golden Tube" After Complete Resorption of a Bioresorbable Vascular Scaffold in a Transplanted Patient With Cardiac Allograft Vasculopathy 132
Long-term intracoronary imaging and physiological measurements of bioresorbable scaffolds and untreated atherosclerotic plaques 127
Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES) 127
Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses. 127
Recurrent very late drug-eluting stent thrombosis. 123
Dynamic changes of repolarization abnormalities in takotsubo cardiomyopathy 123
Choosing transcatheter aortic valve replacement in porcelain aorta: outcomes versus surgical replacement 122
Cardiovascular imaging in arrhythmogenic right ventricular dysplasia/cardiomyopathy 121
Clinical Updates in Coronary Artery Disease: A Comprehensive Review 121
Radial artery occlusion after transradial procedures: impact on 1-year adverse events 121
Early shifts in serum creatinine concentrations can predict contrast-induced nephropathy and persistent renal damage following angiography,Modificazioni precoci nella concentrazione della creatininemia sono in grado di predire la nefropatia da mezzo di contrasto e il danno renale persistente dopo angiografia 121
Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact 118
Repeat revascularization: Percutaneous coronary intervention after coronary artery bypass graft surgery 117
Percutaneous Impella Recover circulatory support in high-risk coronary angioplasty. 114
Long-Term Outcomes of Coronary and Carotid Artery Disease Revascularization in the FRIENDS Study 114
Functional Patterns of Coronary Disease: Diffuse, Focal, and Serial Lesions 110
Osteomyelitis of the clavicle following to a pacemaker implantation 109
Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients 107
Transapical Transcatheter Aortic Valve Replacement: A Real-World Early and Mid-Term Outcome of a Third-Level Centre 107
Intraventricular entrapment of a Sapien-3 balloon in transapical TAVR: A near missed catastrophe 107
Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI 106
Quality of Life after Transcatheter Aortic Valve Replacement in Sarcopenic Patients Using the Toronto Aortic Stenosis Quality of Life Questionnaire 106
Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction 105
Coronary obstruction after transcatheter aortic valve replacement combined with basilica procedure 104
Right Ventricle Pulmonary Artery Coupling and Renal Function in Patients With Severe Aortic Stenosis Undergoing TAVR 104
Incomplete functional revascularization is associated with adverse clinical outcomes after transcatheter aortic valve implantation 103
Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI 100
Transcatheter tricuspid valve implantation by femoral approach in trivalvular heart disease 100
Glucocorticoids in the prevention of restenosis after coronary angioplasty: therapeutic potential. 100
Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience 100
Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction 99
Early and late clinical outcomes of endovascular, surgical, and hybrid revascularization strategies of combined carotid and coronary artery diseases: the FRIENDS study group (Finalized Research In ENDovascular Strategies) 98
Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian REgistry. 98
Predictors of patent and occlusive hemostasis after transradial coronary procedures 97
Ten-year experience with a transapical approach for transcatheter aortic and mitral valve implantation 96
Ten-Year Experience with Endomyocardial Biopsy after Orthotopic Heart Transplantation: Comparison between Trans-Jugular and Trans-Femoral Approach 95
Early Postoperative Thrombosis of Transcatheter Aortic Valve-in-Valve Prosthesis 95
Single-side renal sympathetic denervation to treat malignant refractory hypertension in a solitary kidney patient 95
Is transfemoral aortic valve implantation possible without contrast medium in patients with renal and multiorgan failure? 93
Letter by Ribichini et al regarding article, "Cystatin C and contrast-induced acute kidney injury". 93
Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions 91
Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART) 88
Transfemoral Edwards-Novaflex valve implantation in a patient with aorto-iliac endoprosthesis and severely tortuous bilateral external iliac arteries-"Railing track" 87
Short-and-Long-Term Outcomes after Coronary Rotational Atherectomy in Patients Treated with Trans-Catheter Aortic Valve Implantation 84
Increased Thrombogenicity is Associated With Coronary Microvascular Dysfunction in Patients With STEMI-A Proof-of-Concept Study 83
Transcatheter edge-to-edge mitral valve repair: what is the measure of success? 83
Significant Drop in Right Atrial Pressure Does Not Influence Fractional Flow Reserve Coronary Assessment 78
The promise of vascular reparative therapy in standby mode. How long before a final decision? Complete vessel wall regeneration and vascular scaffold resorption after left anterior descending reconstructions 76
Totale 13.973
Categoria #
all - tutte 54.938
article - articoli 54.426
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 512
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.876


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022384 0 117 5 41 7 5 2 19 16 11 53 108
2022/20231.221 68 179 103 156 92 289 49 68 150 13 36 18
2023/20241.013 22 58 77 125 99 227 48 84 10 69 157 37
2024/20252.325 104 117 103 395 163 113 75 106 369 178 190 412
2025/20267.172 466 278 432 1.318 1.951 487 675 375 576 339 105 170
2026/2027128 84 44 0 0 0 0 0 0 0 0 0 0
Totale 14.297